Associated Papers
Novel first-dose adverse drug reactions during a phase I trial of olipudase alfa (recombinant human acid sphingomyelinase) in adults with Niemann-Pick disease type B (acid sphingomyelinase deficiency).
McGovern MM et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2016
Functional in vitro characterization of 14 SMPD1 mutations identified in Italian patients affected by Niemann Pick Type B disease.
Dardis A et al.
Human Mutation, 2005
Niemann-Pick disease: mutation update, genotype/phenotype correlations, and prospects for genetic testing.
Schuchman EH et al.
Genetic Testing, 1997
Identification and expression of a missense mutation (Y446C) in the acid sphingomyelinase gene from a Japanese patient with type A Niemann-Pick disease.
Takahashi T et al.
The Tohoku Journal of Experimental Medicine, 1995
Identification and expression of five mutations in the human acid sphingomyelinase gene causing types A and B Niemann-Pick disease. Molecular evidence for genetic heterogeneity in the neuronopathic and non-neuronopathic forms.
Takahashi T et al.
The Journal of Biological Chemistry, 1992
Successful within-patient dose escalation of olipudase alfa in acid sphingomyelinase deficiency.
Wasserstein MP et al.
Molecular Genetics and Metabolism, 0
Select a paper to view details